Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
A surge in home insurance premiums is reshaping housing markets across the country, hitting disaster‑prone regions the hardest. From Louisiana to Colorado and California, deals are collapsing, buyers are backing out, and home values are dropping as insurance becomes a central affordability hurdle. New data shows climate‑driven risk repricing and soaring reinsurance costs are stripping tens of thousands of dollars from property values, forcing some homeowners to sell at a loss—or go uninsured altogether.
After years of sluggish activity, the National Association of REALTORS predicts 2026 could mark the long‑awaited rebound for the housing market. With a projected 14% jump in home sales, steadier rates near 6%, and rising buyer activity, NAR economists say momentum is already building. Early signs—like a 31% surge in mortgage applications, continued job growth, and stabilizing prices—suggest a stronger, more confident market ahead, creating fresh opportunities for both seasoned professionals and aspiring agents preparing to enter the field.
A surge of global capital is reshaping real estate heading into 2026, with investors shifting toward hands‑on strategies, cross‑border diversification, and high‑growth asset classes like data centers. Colliers’ 2026 Global Investor Outlook highlights rising confidence, improving liquidity, and a major pivot toward direct investing and value‑add opportunities. From office market rebounds to Asia Pacific’s rapid fundraising growth, the report outlines trends every real estate professional should understand as the industry enters a more dynamic, opportunity‑rich cycle.
Culver City just became the first place in California to legalize six‑story apartment buildings with only one staircase — a simple change that could reshape mid‑rise housing statewide. By freeing up as much as 7% more usable floor space, architects say single‑stair designs allow bigger units, more windows, and the kind of elegant layouts common in New York and Europe. If the city’s six‑year experiment succeeds, it may spark a broader rethinking of U.S. building codes and open the door to more flexible, affordable multifamily development across California.
Stratford homeowners are receiving their 2025 Notices of Assessment Change, marking the town’s first property revaluation since 2019. Officials emphasize that rising assessments do not equal higher tax bills, as a new mill rate won’t be set until spring 2026. Residents can challenge or review their updated valuations through informal hearings hosted by Vision Government Solutions, with appointments available for one week after receiving a notice.
New reporting reveals Florida homeowners now face an average insurance premium of $5,838 per year — nearly triple the national average. With skyrocketing rates, denied claims, and mounting non-renewals, residents are being pushed to tough financial decisions while lawmakers scramble to implement reforms. From retirees skipping coverage to families battling insurers for fair payouts, Florida’s insurance crisis is reshaping both the housing market and the daily lives of homeowners statewide.
